C[MV] You Later: Letermovir for Prevention of Cytomegalovirus Infection

<p>Mikhaila L. Rice, Pharm.D., (@MikhailaPharmD) explains the difference between pre-emptive and prophylaxis strategies for cytomegalovirus infection prevention, selects patients that may benefit from letermovir prophylaxis based on existing literature, and identifies areas of investigational use of letermovir.</p> <p>For more pharmacy content, follow Mayo Clinic Pharmacy Residency Programs <a href='https://twitter.com/MayoPharmRes'>@MayoPharmRes</a> or the host, Garrett E. Schramm, Pharm.D., <a href='https://twitter.com/garrett_schramm'>@garrett_schramm</a> on Twitter!</p> <p>You can also connect with the Mayo Clinic’s School of Continuous Professional Development online at <a href='https://ce.mayo.edu/'>https://ce.mayo.edu/</a> or on Twitter <a href='https://twitter.com/MayoMedEd'>@MayoMedEd</a>. </p>